Penumbra Inc

Common Name
Penumbra
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
4,500
Ticker
PEN
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the co...

Penumbra's Financial Statements Preview

Below are the financial statements of Penumbra, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenue
1,194.62b
1,058.52b
847.13b
Cost of revenue
-439.62b
-375.88b
-311.93b
Gross profit
755b
682.64b
535.21b
Operating expenses
Research and development
-94.78b
-84.42b
-79.41b
Sales, general and administrative
-573.99b
-506.45b
-449.72b
Acquired in-process research and development
0b
-18.22b
0b
Impairment charge
-76.95b
0b
0b
Total operating expenses
-745.72b
-609.09b
-529.13b
Income from operations
9.28b
73.55b
6.08b
Interest and other income (expense), net
11.59b
6.1b
-2.19b
Income before income taxes
20.87b
79.65b
3.89b
Provision for (benefit from) income taxes
-6.86b
-11.3b
-5.89b
Net income (loss)
14.01b
90.95b
-2b
Download Data

Verified Sources Behind Penumbra’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Penumbra’s data sources below and access millions more through our Disclosure Search.

a. Penumbra's 10-K 2024
a. Penumbra's 10-K 2024
b. Penumbra's Annual Report 2024
b. Penumbra's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?